These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 27382574)
21. Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery. Larraufie P; Roberts GP; McGavigan AK; Kay RG; Li J; Leiter A; Melvin A; Biggs EK; Ravn P; Davy K; Hornigold DC; Yeo GSH; Hardwick RH; Reimann F; Gribble FM Cell Rep; 2019 Feb; 26(6):1399-1408.e6. PubMed ID: 30726726 [TBL] [Abstract][Full Text] [Related]
22. Control of insulin secretion by GLP-1. Jones B; Bloom SR; Buenaventura T; Tomas A; Rutter GA Peptides; 2018 Feb; 100():75-84. PubMed ID: 29412835 [TBL] [Abstract][Full Text] [Related]
24. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome. Tzotzas T; Karras SN; Katsiki N Curr Vasc Pharmacol; 2017; 15(3):218-229. PubMed ID: 28003008 [TBL] [Abstract][Full Text] [Related]
25. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent. Lam NT; Kieffer TJ Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501 [TBL] [Abstract][Full Text] [Related]
26. Glucagon-like Peptide-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus and Obesity: The Impact of Pharmacological Properties and Genetic Factors. Klen J; Dolžan V Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408810 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors. Nauck MA; Meier JJ; Cavender MA; Abd El Aziz M; Drucker DJ Circulation; 2017 Aug; 136(9):849-870. PubMed ID: 28847797 [TBL] [Abstract][Full Text] [Related]
28. The incretin system and its role in type 2 diabetes mellitus. Holst JJ; Vilsbøll T; Deacon CF Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Drucker DJ Cell Metab; 2018 Apr; 27(4):740-756. PubMed ID: 29617641 [TBL] [Abstract][Full Text] [Related]
30. Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review. Østergaard L; Frandsen CS; Madsbad S Expert Rev Clin Pharmacol; 2016; 9(2):241-65. PubMed ID: 26573176 [TBL] [Abstract][Full Text] [Related]
31. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. Yabe D; Seino Y Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006 [TBL] [Abstract][Full Text] [Related]
32. Incretin-based therapies: where will we be 50 years from now? Meier JJ; Nauck MA Diabetologia; 2015 Aug; 58(8):1745-50. PubMed ID: 25994073 [TBL] [Abstract][Full Text] [Related]
33. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery. Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780 [TBL] [Abstract][Full Text] [Related]
34. A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents. Nørregaard PK; Deryabina MA; Tofteng Shelton P; Fog JU; Daugaard JR; Eriksson PO; Larsen LF; Jessen L Diabetes Obes Metab; 2018 Jan; 20(1):60-68. PubMed ID: 28598027 [TBL] [Abstract][Full Text] [Related]
35. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors. Neumiller JJ J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361 [TBL] [Abstract][Full Text] [Related]
36. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related]
37. [The physiology of glucagon-like peptide-1 and its role in the pathophysiology of type 2 diabetes mellitus]. Escalada FJ Med Clin (Barc); 2014 Sep; 143 Suppl 2():2-7. PubMed ID: 25437458 [TBL] [Abstract][Full Text] [Related]
38. Measurement of Gastrointestinal Hormones. Albrechtsen NJW Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115211 [TBL] [Abstract][Full Text] [Related]